You are here

Netherton Syndrome

Microbiome Report for Week Ending 4/13/19

Microbiome Report for Week Ending 4/13/19

CP Wire

SkinBio Therapeutics

Netherton Syndrome

Flag link:

Microbiome Report for Week Ending 4/13/19

SkinBio Therapeutics

Netherton Syndrome

Flag link:

Azitra Demonstrates Feasibility of Using the Skin Microbiome to Treat Skin Conditions

Azitra Demonstrates Feasibility of Using the Skin Microbiome to Treat Skin Conditions

CP Wire

Netherton Syndrome

skin microbiome

Flag link:

Azitra Demonstrates Feasibility of Using the Skin Microbiome to Treat Skin Conditions

Netherton Syndrome

Flag link:

LifeMax Acquires Rights to Orphan Drug for Netherton Syndrome from Novartis

LifeMax Acquires Rights to Orphan Drug for Netherton Syndrome from Novartis

CP Wire

LifeMax Laboratories

Netherton Syndrome

Flag link:

LifeMax Acquires Rights to Orphan Drug for Netherton Syndrome from Novartis

LifeMax Laboratories

Netherton Syndrome

Flag link: